|
Aug 13
|
Zai Lab Establishes Oncology Scientific Advisory Board
|
|
Aug 10
|
Here's What Analysts Are Forecasting For Zai Lab Limited (NASDAQ:ZLAB) After Its Second-Quarter Results
|
|
Aug 8
|
Zai Lab Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
|
|
Aug 7
|
Asian Equities Traded in the US as American Depositary Receipts Sharply Higher in Thursday Trading
|
|
Aug 7
|
Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings
|
|
Aug 7
|
Zai Lab Announces Second Quarter 2025 Financial Results and Recent Corporate Updates
|
|
Jul 29
|
Asian Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading
|
|
Jul 28
|
Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading
|
|
Jul 28
|
Tesla Rival Leads 5 China Stocks Near Buy Points Amid Trump Trade Truce Hopes
|
|
Jul 25
|
Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment
|
|
Jul 23
|
Zai Lab Limited (ZLAB) Stock Jumps 6.8%: Will It Continue to Soar?
|
|
Jul 22
|
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
|
|
Jul 18
|
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading; Rise Nearly 3% for Week
|
|
Jul 1
|
Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint
|
|
Jun 30
|
Asian Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
|
|
Jun 30
|
Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer
|
|
Jun 27
|
Asian Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Up 5% for Week
|
|
Jun 2
|
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting
|
|
Apr 25
|
Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025
|
|
Apr 23
|
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting
|